Every week of 2025 seems to bring a new health headline, whether it's about climbing autism rates, changing vaccination ...

Randomized controlled trial results published in the International Journal of Tissue Repair demonstrate BioRetain® allografts significantly improve probability of achieving lasting wound closure versu ...

The evidence that ultra-processed foods are bad for us is piling up. But efforts to reduce their role in our diets face a big ...

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel therapies to manage inflammation, lipids, hypertension, obesity, diabetes and ...

Topline results were announced from a phase 3 study evaluating Moderna’s cytomegalovirus (CMV) vaccine candidate, mRNA-1647.

LLDAS response rate observed in patients with SLE who received Descartes-08 in Phase 2 open-label trial reaching Month 3 follow-up (n=3) ...

The two main types of IBD are ulcerative colitis (UC) and Crohn's disease (CD). Do you or someone you love have moderate to severe UC or CD? You may want to learn about one of two clinical trials. In ...

Since the beginning of this century, advances in understanding the biology of multiple myeloma have transformed the disease ...

Reclassified disease response criteria at 28 days of treatment for acute graft-vs-host disease (GVHD) improved prediction of 6-month nonrelapse mortality (NRM) compared with conventional criteria in ...

Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter ...

For people trying to make informed choices about their own health and that of their families, can be tough to make sense of ...